IMS Health promises privacy protection as the firm goes public

01/6/2014 | Forbes

IMS Health plans an initial public offering, according to a filing with the Securities and Exchange Commission. The firm collects and sells data and reports to pharmaceutical and biotechnology firms, consulting organizations, advertising agencies, and other organizations. Privacy advocates have expressed concern about physician and patient data, but IMS' filing reassured the SEC that the company remains committed to privacy and security.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI